DGAP-Adhoc: Bayerische Motoren Werke Aktiengesellschaft: Preliminary Key Financial Performance Figures of BMW AG for the first quarter 2021 exceed market expectations
2021. április 19., hétfő, 18:52
DGAP-Ad-hoc: Bayerische Motoren Werke Aktiengesellschaft / Key word(s): Quarterly / Interim Statement/Preliminary Results BMW AG reports sales growth in all significant regions of the world, in particular in China, and in all brands in the first quarter of 2021. In addition, positive price and mix effects, as well as high demand for pre-owned cars, also lead to key financial performance figures of BMW AG which exceed market expectations in a positive current environment. Based on preliminary figures for the first quarter 2021, Automotive segment EBIT is €2,236 million (Q1 2020: €229 million), Financial Services segment EBT is €787 million (Q1 2020: €484 million) and Group EBT is €3,757 million (Q1 2020: €798 million). The Automotive segment EBIT margin is 9.8% (Q1 2020: 1.3%). The positive operating performance and the continued focus on working capital management lead to a free cash flow of €2,522 million (Q1 2020: -2,218 million) in the Automotive segment also exceeding market expectations. The definition of the above-mentioned financial indicators is provided on pages 327 and 328 of the BMW Group Report 2020. Further details will be published in the Quarterly Statement for the period to 31 March 2021 on 7 May 2021. Contact: Veronika Rösler Head of Investor Relations Tel.: +49-89-382-25387
|
Language: | English |
Company: | Bayerische Motoren Werke Aktiengesellschaft |
Petuelring 130 | |
80788 Munich | |
Germany | |
Phone: | +49 (0)89 382 0 |
Internet: | www.bmwgroup.com |
ISIN: | DE0005190003, DE0005190037 |
WKN: | 519000 , 519003 |
Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange, SIX |
EQS News ID: | 1186369 |
End of Announcement | DGAP News Service |
1186369 19-Apr-2021 CET/CEST
Közzétételek - archívum
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]